Orthobiologic Treatment for Knee Osteoarthritis

Enrolling by invitation · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Osteoarthritis Knee

In brief

The goal of this randomized clinical trial is to compare treatment for osteoarthritis in the knee using platelet rich plasma (PRP) or adipose stem cells (ADS). The main questions it aims to answer are: * Will the patients clinically benefit from the treatment, and if so, which treatment is better? * Will there be radiological findings to support this? Participants will be randomized into one of four groups: PRP, ADS, PRP + ADS or placebo treatment (saline) and will be examined and get an X-ray and MRI of the knee taken at inclusion and after 1 and 2 years.

Key facts

Study ID
NCT06893250
Run by
University Hospital of North Norway
People needed
160
Starts
2024-09-23
Expected to finish
2027-12-01
Last updated by the study team
2026-06-15

Who can join

Age: 40 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.